ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

NIEHS Awards $5M Grant for New Health Sciences Center to Robert Wood Johnson Medical School

January 20, 1989

Cooney to Oversee University of Michigan Clinical Operations

February 7, 2013

Working Group To Review NCI Clinical Trials Programs

April 12, 1996

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

Simone Retires From Academic Medicine, But Plans To Remain Active In Advisory Roles.

September 7, 2001

In Brief: GAO Studying Cancer Program So Congress Will Have Own Data; NCI Job Freeze Still Hurts Program

February 21, 1975